The roadmap suggests those with the greatest clinical need will get priority access, according to the NHS national medical ...
NHS England plans a phased rollout of tirzepatide to treat severe obesity, with early trials showing significant weight loss.
While Mounjaro was cleared for use in England last year, Lilly put its launch on hold until its pre-filled injection device, ...
After nearly two years, federal regulators announced the shortage of the active ingredient in Mounjaro and Zepbound has been ...
The Medicine Foundry, which is expected to create 400 jobs, will be situated in the LEAP Research and Innovation District in ...